在葡萄糖-6-酸脱酶缺陷患者的梅特福林诱导血液溶解:一个病例报告
Adil Jumani1, Hadiza Ibrahim1, Hana Purra1
1Internal Medicine, Zayed Military Hospital, Abu Dhabi, ARE.
Cureus
|August 22, 2024
概括
甲福明可以在患有葡萄糖-6-酸脱酶 (G6PD) 缺乏症的人中引起罕见的溶血危机. 这一案例凸显了在开药前对高风险患者进行查的重要性.
科学领域:
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 甲胺是治疗2型糖尿病和其他疾病的首要治疗方法,如胰岛素耐药性和多囊性卵巢综合征.
- 虽然通常耐受性很好,但在特定的高风险患者群体中,甲胺可能会导致不良反应.
- 一种罕见但严重的副作用是引发血解危机.
研究的目的:
- 在患有葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症的患者中报告甲胺诱导的血解危机病例.
- 强调在开始服用甲福林之前确定G6PD缺乏的重要性.
- 为了提高人们对这种罕见的药物不良反应的认识.
主要方法:
- 一个中年男性患者的病例报告,诊断出患有新发型糖尿病.
- 开始接受甲福明治疗并随后对副作用进行监测.
- 诊断工作包括血液溶解和G6PD缺陷的测试.
- 停止涉嫌犯罪的代理人和支持性护理.
主要成果:
- 患者的血红蛋白水平急剧下降,被诊断为血液溶解危机.
- 葡萄糖-6-酸盐脱酶 (G6PD) 缺乏被确定为潜在原因.
- 通过广泛的测试,其他潜在的血液溶解原因被排除在外.
- 患者的病情在停止甲福明和支持性治疗后得到改善.
结论:
- 在有G6PD缺乏的人群中,甲福明可以加速血液溶解危机.
- 在开药前对高风险人群进行G6PD缺乏症查至关重要.
- 这一案例强调了对罕见药物副作用的警的必要性.
相关概念视频
01:27Glucose Transporters
22.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520
01:23Dipeptidyl Peptidase 4 Inhibitors
179
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
179
01:20Pathophysiology of Diabetes
908
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908